Home › Funds › Cormorant Asset Management, LP › COGT
Cormorant Asset Management, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Cormorant Asset Management, LP reported holding 100,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 0.20% of its reported portfolio and ranking #44 among its reported holdings. Cormorant Asset Management, LP has disclosed COGT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's COGT position evolved
Cormorant Asset Management, LP first disclosed a stake in COGT in Q3 2023 at 1,000,000 shares (US$9.8M). Across 4 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 100,000 shares valued at US$3.9M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 50% trim in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.00M | $9.75M | New |
| Q4 2025 | 225.00K | $7.99M | New |
| Q1 2026 | 200.00K | $7.70M | Reduce |
| Q2 2026 | 100.00K | $3.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Kynam Capital Management, LP 3.67M sh · $141.92M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Siren, L.L.C. 1.86M sh · $71.95M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $62.05M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.28M sh · $49.56M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held COGT?
Cormorant Asset Management, LP has disclosed COGT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in COGT?
As of Q2 2026, Cormorant Asset Management, LP holds 100.00K shares of COGT (COGENT BIOSCIENCES INC), valued at $3.87M, representing 0.20% of its reported portfolio and ranking #44.
Has Cormorant Asset Management, LP been buying or selling COGT?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in COGT.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.